Eosinophil-epithelial cell interactions stimulate the production of MUC5AC mucin and profibrotic cytokines involved in airway tissue remodeling

American Journal of Rhinology and Allergy

Volumn 28, Issue 2, 2014, Pages 103-109

  Shimizu, Shino ^a   Kouzaki, Hideaki ^a   Ogawa, Takao ^a   Takezawa, Kumiko ^a   Tojima, Ichiro ^a   Shimizu, Takeshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; AMPHIREGULIN; ILOMASTAT; INTERLEUKIN 8; MUCIN 5AC; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR AB; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; CYTOKINE; DIPEPTIDE; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; MUC5AC PROTEIN, HUMAN; N-(2(R)-2-(HYDROXAMIDOCARBONYLMETHYL)-4-METHYLPENTANOYL)-L-TRYPTOPHAN METHYLAMIDE; QUINAZOLINE DERIVATIVE; TYRPHOSTIN;

AIRWAY REMODELING; ARTICLE; BLOOD; CELL CONTACT; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EPITHELIUM CELL; HUMAN; HUMAN CELL; PATHOGENESIS; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ASTHMA; BODILY SECRETIONS; CELL COMMUNICATION; CELL LINE; DRUG EFFECTS; FIBROSIS; GENETICS; IMMUNIZATION; IMMUNOLOGY; METABOLISM; NOSE POLYP; PATHOLOGY; RESPIRATORY SYSTEM; TRANSCRIPTION INITIATION;

AIRWAY REMODELING; AMPHIREGULIN; ASTHMA; BODILY SECRETIONS; CELL COMMUNICATION; CELL LINE; COCULTURE TECHNIQUES; CYTOKINES; DIPEPTIDES; EOSINOPHILS; EPITHELIAL CELLS; FIBROSIS; HUMANS; IMMUNIZATION; MUCIN 5AC; NASAL POLYPS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESPIRATORY SYSTEM; TRANSCRIPTIONAL ACTIVATION; TYRPHOSTINS;

EID: 84897144805     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2014.28.4018     Document Type: Article

References (33)

1. Pawankar R, and Nonaka M. Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps. Curr Allergy Asthma Rep 7:202-208, 2007. (Pubitemid 46784199)
2. Al-Muhsen S, Johnson JR, and Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 128:451-462, 2011.
3. Kay AB, Phipps S, and Robinson DS. A role for eosinophils in airway remodelling in asthma. Trends Immunol 25:477-482, 2004. (Pubitemid 39490254)
4. Kita H. Eosinophils: Multifaceted biological properties and roles in health and disease. Immunol Rev 242:161-177, 2011.
5. Proud D, and Leigh R. Epithelial cells and airway diseases. Immunol Rev 242:186-204, 2011.
6. Dent G, Rühlmann E, Bodtke K, et al. Up-regulation of human eosinophil leukotriene C4 generation through contact with bronchial epithelial cells. Inflamm Res 49:236-239, 2000. (Pubitemid 30353689)
7. Wang CB, Wong CK, Ip WK, et al. Induction of IL-6 in co-culture of bronchial epithelial cells and eosinophils is regulated by p38 MAPK and NF-kappaB. Allergy 60:1378-1385, 2005. (Pubitemid 41476180)
8. Wong CK, Wang CB, Ip WK, et al. Role of p38 MAPK and NF-kB for chemokine release in coculture of human eosinophils and bronchial epithelial cells. Clin Exp Immunol 139:90-100, 2005. (Pubitemid 40066133)
9. Burgel PR, Lazarus SC, Tam DC, et al. Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation. J Immunol 167:5948-5954, 2001. (Pubitemid 33062791)
10. Kouzaki H, Seno S, Fukui J, et al. Role of platelet-derived growth factor in airway remodeling in rhinosinusitis. Am J Rhinol Allergy 23:273-280, 2009.
11. Lee CG, Link H, Baluk P, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10:1095-1103, 2004. (Pubitemid 39424871)
12. Halwani R, Al-Muhsen S, Al-Jahdali H, et al. Role of transforming growth factor-β in airway remodeling in asthma. Am J Respir Cell Mol Biol 44:127-133, 2011.
13. Ono N, Kusunoki T, and Ikeda K. Relationships between IL-17A and macrophages or MUC5AC in eosinophilic chronic rhinosinusitis and proposed pathological significance. Allergy Rhinol (Providence) 3:e50-e54, 2012.
14. Rose MC, and Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86:245-278, 2006.
15. Thornton DJ, and Sheehan JK. From mucins to mucus: Toward a more coherent understanding of this essential barrier. Proc Am Thorac Soc 1:54-61, 2004.
16. Kato M, Kimura H, Motegi Y, et al. Platelet-activating factor activates two distinct effector pathways in human eosinophils. J Immunol 169:5252-5259, 2002. (Pubitemid 35217197)
17. Shimizu S, Shimizu T, Morser J, et al. Role of the coagulation system in allergic inflammation in the upper airways. Clin Immunol 129:365-371, 2008.
18. Increase the power and sensitivity of cDMA synthesis. www.roche-applied-science.com/sis/rtpcr/upl/adc.jsp.
19. Sexton DW, and Walsh GM. Eosinophil-epithelial cell interactions: An important facet of asthmatic inflammation. Clin Exp Allergy 32:811-813, 2002. (Pubitemid 34626074)
20. Feltis BN, Wignarajah D, Zheng L, et al. Increased vascular endothelial growth factor and receptors: Relationship to angiogenesis in asthma. Am J Respir Crit Care Med 173:1201-1207, 2006. (Pubitemid 43848389)
21. Wittekindt C, Hess A, Bloch W, et al. Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol 259:294-298, 2002. (Pubitemid 34762303)
22. Zaravinos A, Soufla G, Bizakis J, et al. Expression analysis of VEGFA, FGF2, TGFbeta1, EGF and IGF1 in human nasal polyposis. Oncol Rep 19:385-391, 2008. (Pubitemid 351176098)
23. Otto BA, and Wenzel SE. The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg 16:270-274, 2008. (Pubitemid 351677664)
24. Nakagome K, Matsushita S, and Nagata M. Neutrophilic inflammation in severe asthma. Int Arch Allergy Immunol 158(suppl 1):96-102, 2012.
25. Polosa R, Prosperini G, Tomaselli V, et al. Expression of c-erbB receptors and ligands in human nasal epithelium. J Allergy Clin Immunol 106:1124-1131, 2000. (Pubitemid 32006267)
26. Burgel PR, Escudier E, Coste A, et al. Relation of epidermal growth factor receptor expression to goblet cell hyperplasia in nasal polyps. J Allergy Clin Immunol 106:705-712, 2000.
27. Burgel PR, and Nadel JA. Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 32:1068-1081, 2008.
28. Normanno N, De Luca A, Bianco C, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366:2-16, 2006. (Pubitemid 43199589)
29. Polosa R, Prosperini G, Leir SH, et al. Expression of c-erbB receptors and ligands in human bronchial mucosa. Am J Respir Cell Mol Biol 20:914-923, 1999. (Pubitemid 129540850)
30. Larsen AK, Ouaret D, El Ouadrani K, et al. Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol Ther 131:80-90, 2011.
31. Ohtsu H, Dempsey PJ, and Eguchi S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 291:C1-C10, 2006.
32. Hur GY, Lee SY, Lee SH, et al. Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation. Exp Mol Med 39:367-375, 2007.
33. Kung YC, Lin CC, Liaw SF, et al. Effects of erlotinib on pulmonary function and airway remodeling after sensitization and repeated allergen challenge in Brown-Norway rats. Respir Physiol Neurobiol 175:349-356, 2011.